MedPath

RIVA-OLANZAPINE ODT

RIVA-OLANZAPINE ODT

Discontinued
DIN Number

02339846

Drug Class

Human

Market Date

Feb 17, 2010

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02339846
AIG Number0128783005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH03 OLANZAPINE
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

OLANZAPINEActive
Strength: 15 MG
Monograph: OLANZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.